3D Modeling: Insights into the Metabolic Reprogramming of Cholangiocarcinoma Cells.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
13 Sep 2024
Historique:
received: 26 08 2024
revised: 05 09 2024
accepted: 08 09 2024
medline: 27 9 2024
pubmed: 27 9 2024
entrez: 27 9 2024
Statut: epublish

Résumé

Developing accurate in vitro models that replicate the in vivo tumor environment is essential for advancing cancer research and therapeutic development. Traditional 2D cell cultures often fail to capture the complex structural and functional heterogeneity of tumors, limiting the translational relevance of findings. In contrast, 3D culture systems, such as spheroids, provide a more physiologically relevant context by replicating key aspects of the tumor microenvironment. This study aimed to compare the metabolism of three intrahepatic cholangiocarcinoma cell lines in 2D and 3D cultures to identify metabolic shifts associated with spheroid formation. Cells were cultured in 2D on adhesion plates and in 3D using ultra-low attachment plates. Metabolic exchange rates were measured using NMR, and intracellular metabolites were analyzed using LC-MS. Significant metabolic differences were observed between 2D and 3D cultures, with notable changes in central carbon and glutathione metabolism in 3D spheroids. The results suggest that 3D cultures, which more closely mimic the in vivo environment, may offer a more accurate platform for cancer research and drug testing.

Identifiants

pubmed: 39329720
pii: cells13181536
doi: 10.3390/cells13181536
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Italian Association for Cancer Research
ID : IG23117

Auteurs

Giorgia Ciufolini (G)

Department of Chemical Science and Technology, University of Rome "Tor Vergata", 00133 Rome, Italy.

Serena Zampieri (S)

Department of Chemical Science and Technology, University of Rome "Tor Vergata", 00133 Rome, Italy.

Simona Cesaroni (S)

Department of Chemical Science and Technology, University of Rome "Tor Vergata", 00133 Rome, Italy.

Valentina Pasquale (V)

Department of Biotechnology and Biosciences, University of Milan-Bicocca, 20126 Milan, Italy.
SYSBIO-ISBE-IT-Candidate National Node of Italy for ISBE, Research Infrastructure for Systems Biology Europe, 20126 Milan, Italy.

Marcella Bonanomi (M)

SYSBIO-ISBE-IT-Candidate National Node of Italy for ISBE, Research Infrastructure for Systems Biology Europe, 20126 Milan, Italy.
Institute of Bioimaging and Complex Biological Systems (IBSBC), 20054 Segrate, Italy.

Daniela Gaglio (D)

SYSBIO-ISBE-IT-Candidate National Node of Italy for ISBE, Research Infrastructure for Systems Biology Europe, 20126 Milan, Italy.
Institute of Bioimaging and Complex Biological Systems (IBSBC), 20054 Segrate, Italy.

Elena Sacco (E)

Department of Biotechnology and Biosciences, University of Milan-Bicocca, 20126 Milan, Italy.
SYSBIO-ISBE-IT-Candidate National Node of Italy for ISBE, Research Infrastructure for Systems Biology Europe, 20126 Milan, Italy.

Marco Vanoni (M)

Department of Biotechnology and Biosciences, University of Milan-Bicocca, 20126 Milan, Italy.
SYSBIO-ISBE-IT-Candidate National Node of Italy for ISBE, Research Infrastructure for Systems Biology Europe, 20126 Milan, Italy.

Mirella Pastore (M)

Department of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy.

Fabio Marra (F)

Department of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy.

Daniel Oscar Cicero (DO)

Department of Chemical Science and Technology, University of Rome "Tor Vergata", 00133 Rome, Italy.

Chiara Raggi (C)

Department of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy.

Greta Petrella (G)

Department of Chemical Science and Technology, University of Rome "Tor Vergata", 00133 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH